True North Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-765
Closed -$298K 219
2025
Q2
$298K Sell
765
-2,947
-79% -$1.19M 0.06% 182
2025
Q1
$1.61M Sell
3,712
-942
-20% -$378K 0.29% 76
2024
Q4
$1.72M Buy
+4,654
New +$1.95M 0.4% 46

Other funds holding ELV

True North Advisors's ELV Position: Q3 2025 in Review

True North Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 765 shares — an estimated $298K sold.

True North Advisors first reported a position in ELV in Q4 2024 and held it in 3 quarters. The position peaked at $1.72M in Q4 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • True North Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • True North Advisors sold 765 Elevance Health shares in Q3 2025, an estimated $298K.
  • True North Advisors first reported a position in Elevance Health in Q4 2024 and held it in 3 quarters.
  • True North Advisors's Elevance Health position peaked at $1.72M in Q4 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on True North Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.